A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
Clinical trial NCT07006792 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07006792
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2026-05-14
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.